blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1711494

EP1711494 - ARYL SUBSTITUTED HETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.04.2011
Database last updated on 25.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2010/23]
Former [2006/42]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / SCHWINK, Lothar
Am Hintertor 2
35260 Stadtallendorf / DE
02 / STENGELIN, Siegfried
Sachsenring 27
65817 Eppstein / DE
03 / BOEHME, Thomas
Höngenstrasse 49
65428 Rüsselsheim / DE
04 / GOSSEL, Matthias
Im Lorsbachtal 17a
65428 Hofheim / DE
05 / HESSLER, Gerhard
Im Langewann 53
65719 Hofheim / DE
06 / LENNIG, Petra
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main / DE
 [2006/52]
Former [2006/42]01 / SCHWINK, Lothar
Am Hintertor 2
35260 Stadtallendorf / DE
02 / STENGELIN, Siegfried
Sachsenring 27
65817 Eppstein / DE
03 / BOEHME, Thomas
Höngenstrasse 49
65428 Rüsselsheim / DE
04 / GOSSEL, Matthias
Im Lorsbachtal 17a
65428 Hofheim / DE
05 / HESSLER, Gerhard
Im Langewann 53
65719 Hofheim / DE
06 / STAHL, Petra
Pestalozzistrasse 16
60385 Frankfurt / DE
Application number, filing date05701163.725.01.2005
[2006/42]
WO2005EP00699
Priority number, dateDE2004100381225.01.2004         Original published format: DE102004003812
[2006/42]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2005070925
Date:04.08.2005
Language:DE
[2005/31]
Type: A1 Application with search report 
No.:EP1711494
Date:18.10.2006
Language:DE
The application published by WIPO in one of the EPO official languages on 04.08.2005 takes the place of the publication of the European patent application.
[2006/42]
Type: B1 Patent specification 
No.:EP1711494
Date:09.06.2010
Language:DE
[2010/23]
Search report(s)International search report - published on:EP04.08.2005
ClassificationIPC:C07D413/10, C07D413/14, C07D417/14, C07D417/10, C07D491/113, A61K31/4245, A61P3/04, A61P3/10
[2006/42]
CPC:
C07D491/10 (EP); C07D413/10 (EP,KR); A61P25/18 (EP);
A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/30 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P7/02 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D413/14 (EP,KR); C07D417/10 (EP);
C07D417/14 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/42]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:ARYLSUBSTITUIERTE HETEROZYKLEN, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL[2006/42]
English:ARYL SUBSTITUTED HETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS[2006/42]
French:HETEROCYCLES ARYL-SUBSTITUES, PROCEDE POUR LEUR PRODUCTION ET LEUR UTILISATION COMME MEDICAMENTS[2006/42]
Entry into regional phase25.08.2006National basic fee paid 
25.08.2006Designation fee(s) paid 
25.08.2006Examination fee paid 
Examination procedure24.11.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.08.2006Examination requested  [2006/42]
25.06.2007Despatch of a communication from the examining division (Time limit: M06)
22.11.2007Reply to a communication from the examining division
11.09.2008Despatch of a communication from the examining division (Time limit: M04)
07.01.2009Reply to a communication from the examining division
21.12.2009Communication of intention to grant the patent
26.04.2010Fee for grant paid
26.04.2010Fee for publishing/printing paid
Opposition(s)10.03.2011No opposition filed within time limit [2011/20]
Fees paidRenewal fee
31.01.2007Renewal fee patent year 03
31.01.2008Renewal fee patent year 04
02.02.2009Renewal fee patent year 05
01.02.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY09.06.2010
CZ09.06.2010
EE09.06.2010
HU09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
TR09.06.2010
BG09.09.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
LU25.01.2011
ES26.01.2011
SE26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
[2013/45]
Former [2013/44]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
TR09.06.2010
BG09.09.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
LU25.01.2011
ES26.01.2011
SE26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2013/42]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
BG09.09.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
LU25.01.2011
ES26.01.2011
SE26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2013/25]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
LU25.01.2011
ES26.01.2011
SE26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2013/21]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
ES26.01.2011
SE26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2013/07]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
AT25.01.2011
FI25.01.2011
IE25.01.2011
IT25.01.2011
ES26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/23]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
IE25.01.2011
IT25.01.2011
ES26.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/10]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
IE25.01.2011
IT25.01.2011
BE31.01.2011
CH31.01.2011
DK31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/08]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
IE25.01.2011
IT25.01.2011
BE31.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/03]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
IT25.01.2011
BE31.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2012/01]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
BE31.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2011/49]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
FI25.01.2011
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2011/48]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
CH31.01.2011
LI31.01.2011
MC31.01.2011
Former [2011/42]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
MC31.01.2011
Former [2011/13]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
IS09.10.2010
Former [2011/11]CY09.06.2010
CZ09.06.2010
EE09.06.2010
LT09.06.2010
PL09.06.2010
RO09.06.2010
SI09.06.2010
SK09.06.2010
Former [2011/05]CY09.06.2010
LT09.06.2010
PL09.06.2010
SI09.06.2010
Former [2011/04]LT09.06.2010
PL09.06.2010
SI09.06.2010
Former [2010/52]LT09.06.2010
SI09.06.2010
Cited inInternational search[X]WO9726258  (JANSSEN PHARMACEUTICA NV [BE], et al) [X] 1-8,10,11,14,17 * page 11, line 34; claims 1,8,9 * * table 2; compounds 17,67,70 * * table 7; compound 167 *;
 [X]WO0066578  (PFIZER PROD INC [US], et al) [X] 1-17 * examples 2,10,49,50,52,63,64,89,109,110 * * claims 42,50 * * pages 69-73 *;
 [X]WO0078758  (WELFIDE CORP [JP]) [X] 1-8,10,11,14 * claim 1 * * page 36 - page 37; examples 31,32 * * page 64 - page 65; examples 85-88 * * page 72 - page 73; examples 104,105 * * page 102 - page 103; examples 29-31 *;
 [X]WO0182930  (TULARIK INC [US], et al) [X] 1,8,10,11,14 * claim 1 * * examples 19,23-25 *;
 [X]WO02079200  (PFIZER LTD [GB], et al) [X] 1-8,10,11,14 * page 58; compounds 37,38 * * page 84; compound 78 * * page 133 - page 135; compounds 80-83 * * claim 1 *;
 [AD]WO03087044  (7TM PHARMA AS [DK], et al) [AD] 1-17 * claims 1,12 *;
 [X]WO03089418  (BAYER PHARMACEUTICALS CORP [US], et al) [X] 1-17 * claims 1,11,14 * * page 82; example 177 * * page 97 - page 99 *;
 [DA]WO03097047  (LILLY CO ELI [US], et al) [DA] 1-17 * claim - *;
 [PA]WO2004072025  (AVENTIS PHARMA GMBH [DE]) [PA] 1-17* claim - *;
 [PX]WO2004111045  (GLAXO GROUP LTD [GB], et al) [PX] 1 * pages 23-28; compounds 3,4,11,12,15,16 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.